Pomanda estimates the enterprise value of MAYA PHARMACARE LIMITED at £2.6m based on a Turnover of £5.7m and 0.46x industry multiple (adjusted for size and gross margin).
maya pharmacare limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of MAYA PHARMACARE LIMITED at £0 based on an EBITDA of £-445.4k and a 3.55x industry multiple (adjusted for size and gross margin).
maya pharmacare limitedEstimated Valuation
£1.4m
Pomanda estimates the enterprise value of MAYA PHARMACARE LIMITED at £1.4m based on Net Assets of £597.7k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Maya Pharmacare LimitedOverview
Maya Pharmacare Limited is a live company located in waltham cross, EN7 6SU with a Companies House number of 10745039. It operates in the other human health activities sector, SIC Code 86900. Founded in April 2017, it's largest shareholder is
reyu holdings limited
with a 98.1% stake. Maya Pharmacare Limited is a young,
mid sized company, Pomanda has estimated its turnover at
£5.7m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Maya Pharmacare Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
5 Strong
1 Regular
4 Weak
Size
annual sales of £5.7m, make it larger than the average company (£649k)
£5.7m - Maya Pharmacare Limited
£649k - Industry AVG
Growth
3 year (CAGR) sales growth of 43%, show it is growing at a faster rate (8%)
43% - Maya Pharmacare Limited
8% - Industry AVG
Production
with a gross margin of 23.1%, this company has a higher cost of product (39.1%)
23.1% - Maya Pharmacare Limited
39.1% - Industry AVG
Profitability
an operating margin of -7.8% make it less profitable than the average company (5.6%)
-7.8% - Maya Pharmacare Limited
5.6% - Industry AVG
Employees
with 66 employees, this is above the industry average (16)
66 - Maya Pharmacare Limited
16 - Industry AVG
Pay Structure
on an average salary of £27.3k, the company has an equivalent pay structure (£27.3k)
£27.3k - Maya Pharmacare Limited
£27.3k - Industry AVG
Efficiency
resulting in sales per employee of £86.3k, this is more efficient (£49.3k)
£86.3k - Maya Pharmacare Limited
£49.3k - Industry AVG
Debtor Days
it gets paid by customers after 64 days, this is later than average (20 days)
64 days - Maya Pharmacare Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 34 days, this is slower than average (17 days)
34 days - Maya Pharmacare Limited
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Maya Pharmacare Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Maya Pharmacare Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 40.7%, this is a higher level of debt than the average (25.8%)
40.7% - Maya Pharmacare Limited
25.8% - Industry AVG
MAYA PHARMACARE LIMITED financials
EXPORT
Maya Pharmacare Limited's latest turnover from April 2024 is estimated at £5.7 million and the company has net assets of £597.7 thousand. According to their latest financial statements, we estimate that Maya Pharmacare Limited has 66 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Turnover
5,697,008
9,738,913
3,934,428
1,950,040
1,924,712
1,980,432
Other Income Or Grants
Cost Of Sales
4,379,562
7,611,027
3,085,942
1,561,019
1,506,834
1,557,960
Gross Profit
1,317,446
2,127,886
848,486
389,020
417,878
422,472
Admin Expenses
1,762,867
1,434,383
581,640
-142,311
558,526
401,549
-46,275
Operating Profit
-445,421
693,503
266,846
531,331
-140,648
20,923
46,275
Interest Payable
23,264
22,402
Interest Receivable
60
40
Pre-Tax Profit
-445,421
693,503
266,846
531,331
-140,648
-2,281
23,912
Tax
-173,376
-50,701
-100,953
-4,543
Profit After Tax
-445,421
520,127
216,145
430,378
-140,648
-2,281
19,369
Dividends Paid
Retained Profit
-445,421
520,127
216,145
430,378
-140,648
-2,281
19,369
Employee Costs
1,801,503
2,972,803
1,184,330
610,606
571,376
566,925
Number Of Employees
66
115
49
26
25
25
EBITDA*
-445,421
693,503
266,846
531,331
-140,648
20,923
46,275
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Tangible Assets
773,894
997,428
1,107,984
1,218,540
Intangible Assets
1,105,562
Investments & Other
102,728
Debtors (Due After 1 year)
Total Fixed Assets
773,894
997,428
1,107,984
1,218,540
1,208,290
Stock & work in progress
Trade Debtors
1,008,366
2,189,044
689,122
142,601
174,478
153,870
Group Debtors
Misc Debtors
4,453
Cash
15,928
misc current assets
total current assets
1,008,366
2,189,044
689,122
142,601
174,478
153,870
20,381
total assets
1,008,366
2,189,044
1,463,016
1,140,029
1,282,462
1,372,410
1,228,671
Bank overdraft
63,594
Bank loan
Trade Creditors
410,424
24,790
572,865
612,624
562,114
625,708
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
410,424
24,790
572,865
612,624
562,114
625,708
63,594
loans
625,708
hp & lease commitments
Accruals and Deferred Income
273
653
700
other liabilities
1,120,511
367,188
220,587
843,208
729,614
519,900
provisions
total long term liabilities
273
1,121,164
367,188
220,587
843,908
729,614
1,145,608
total liabilities
410,697
1,145,954
940,053
833,211
1,406,022
1,355,322
1,209,202
net assets
597,669
1,043,090
522,963
306,818
-123,560
17,088
19,469
total shareholders funds
597,669
1,043,090
522,963
306,818
-123,560
17,088
19,469
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Operating Activities
Operating Profit
-445,421
693,503
266,846
531,331
-140,648
20,923
46,275
Depreciation
Amortisation
Tax
-173,376
-50,701
-100,953
-4,543
Stock
Debtors
-1,180,678
1,499,922
546,521
-31,877
20,608
149,417
4,453
Creditors
385,634
-548,075
-39,759
50,510
-63,594
625,708
Accruals and Deferred Income
-380
653
-700
700
Deferred Taxes & Provisions
Cash flow from operations
1,120,511
-1,527,217
-370,135
512,065
-224,150
497,214
37,279
Investing Activities
capital expenditure
773,894
223,534
110,556
110,556
-112,978
-1,105,562
Change in Investments
-102,728
102,728
cash flow from investments
773,894
223,534
110,556
110,556
-10,250
-1,208,290
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
-625,708
625,708
Hire Purchase and Lease Commitments
other long term liabilities
-1,120,511
753,323
146,601
-622,621
113,594
209,714
519,900
share issue
-100
100
interest
-23,204
-22,362
cash flow from financing
-1,120,511
753,323
146,601
-622,621
113,594
-439,298
1,123,346
cash and cash equivalents
cash
-15,928
15,928
overdraft
-63,594
63,594
change in cash
47,666
-47,666
maya pharmacare limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for maya pharmacare limited. Get real-time insights into maya pharmacare limited's credit score, group structure and payment trends.
Perform a competitor analysis for maya pharmacare limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in EN7 area or any other competitors across 12 key performance metrics.
maya pharmacare limited Ownership
MAYA PHARMACARE LIMITED group structure
Maya Pharmacare Limited has 3 subsidiary companies.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to maya pharmacare limited. Currently there are 2 open charges and 2 have been satisfied in the past.
maya pharmacare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MAYA PHARMACARE LIMITED. This can take several minutes, an email will notify you when this has completed.
maya pharmacare limitedCompanies House Filings - See Documents
